Sphingosine 1-phosphate/S1P receptor axis as a molecular target for therapeutic intervention after spinal cord injury
Project/Area Number |
22591641
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Orthopaedic surgery
|
Research Institution | Jichi Medical University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
OHMORI Tsukasa 自治医科大学, 医学部, 講師 (70382843)
|
Project Period (FY) |
2010 – 2012
|
Project Status |
Completed (Fiscal Year 2012)
|
Budget Amount *help |
¥3,770,000 (Direct Cost: ¥2,900,000、Indirect Cost: ¥870,000)
Fiscal Year 2012: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2011: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2010: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Keywords | 脊髄損傷 / 生理活性脂質 / 血管透過性 / アストロサイト / スフィンゴシン1-リン酸 / 2次損傷 |
Research Abstract |
FTY720 is phosphorylated in vivo to produce the active metabolite FTY720-P, which is a nonselective S1P receptor agonist for four of the five known S1P receptors. We examined the therapeutic effects of FTY720 on locomotor recovery after SCI in mice. Oral
|
Report
(4 results)
Research Products
(6 results)